Q1 2023 Holdings
Filed 2023-05-11 | 7 holdings | $48.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $22.5M | 498,558 | 47.0% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $9.9M | 3,561,150 | 20.6% |
| Passage Bio, Inc. | Common Stock | 702712100 | $4.7M | 4,959,769 | 9.9% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $4.7M | 543,753 | 9.9% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $3.6M | 5,068,233 | 7.6% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $2.0M | 2,320,381 | 4.2% |
| Minerva Surgical Inc. | Common Stock | 60343F106 | $367.4K | 1,673,700 | 0.8% |